Drug Abuse Testing Market COVID-19 Scenario, Growth Opportunities, Industry Analysis and Business Statistics By 2027 | Redwood Toxicology Laboratory (Abbott), F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, OraSure Technologies, UCP Biosciences and o

The Insight Partners published a new report, titled, “Drug Abuse Testing Market”. The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain a thorough understanding of the industry and determine steps to be taken to gain a competitive advantage.

The COVID-19 outbreak is currently going the world over, the Drug Abuse Testing market report covers the impact of the corona-virus on top company’s growth. This research report categorizes as the key players in the Hot Drug Abuse Testing market and also gives a comprehensive study of Covid-19 impact analysis of the market by regions like (Americas, Europe APAC, and EMEA).

The report offers key drivers that propel the growth in the global Drug Abuse Testing market. These insights help market players in devising strategies to gain market presence. The research also outlined the restraints of the market. Insights on opportunities are mentioned to assist market players in taking further steps by determining the potential in untapped regions.

Download Sample Report of Drug Abuse Testing Market Report @ https://www.theinsightpartners.com/sample/TIPHE100001303/?openpr-10225

(*If you have any special requirements, please let us know and we will offer you the report as you want.)

The global drug abuse testing market expected to be US$ 5,783.71 Mn in 2018 and is predicted to grow at a CAGR of 5.7% during the forecast period 2019 - 2027, to reach US$ 9,393.17 Mn by 2027.

Some of the Major Market Players Are:

Redwood Toxicology Laboratory (Abbott)
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific, Inc.
OraSure Technologies, Inc.
UCP Biosciences
MEDACX Ltd.
Beckman Coulter, Inc. (Danaher)
Alcolizer Pty Ltd.
Wondfo
DRÄGERWERK AG & CO. KGAA
American Screening Corporation, Inc
Mercedes Medical, Alfa Scientific Designs, Inc.
Express Diagnostics Int'l, Inc.
Omega Laboratories, Inc.
Laboratorio Sodré.

Market Insights

Increasing Consumption of Illicit Drugs
Illicit drugs, including cocaine, amphetamines, heroin, hallucinogens are substances that can inhibit the central nervous system and also cause hallucinogenic effects. The National Household Survey on Drug Abuse (NSDUH) is a primary source of information on the patterns, prevalence, and consequences of alcohol, illegal drug use, and abuse in the general U.S.

As per statistics provided by the National Survey on Drug Use and Health (NSDUH), approximately 19.7 million American adults (above 12 years of age) have faced a substance use disorder in 2017. According to SAMHSAM, marijuana is the most commonly used illicit drug in the United States. The laws regarding the use of marijuana have changed in several countries over the past decades. Marijuana classified as a Schedule I drug that is considered as having a high potential for drug abuse that has no currently accepted medical use in treatment in the United States yet. Almost 38% of the adult population in the U.S. have battled an illegal drug use disorder during the year 2017. Other than illicit drugs, the consumption of alcohol has observed among the individuals in the country. Nearly 74% of adults suffering from a substance use disorder in 2017 also struggled with an alcohol use disorder.

Across the United States, the increasing consumption of marijuana has a public health impact on local and state communities. As in results, people meeting the diagnostic standards for abuse or dependence on marijuana, which is the second leading factor for which people receive drug treatment (behind alcohol). As per the White House Office of National Drug Control Policy, the consequences of marijuana use have placed a substantial strain on the U.S. health care system. Therefore, owing to the factors mentioned above, the market for drug abuse testing is anticipated to grow significantly in the forecast period.

MARKET SEGMENTATION

By Product

• Rapid Testing Devices
• Analyzers
• Consumables

By Sample Type

• Urine
• Saliva
• Blood
• Others

By End User

• Hospitals
• Diagnostic Laboratories
• Forensic Laboratories

Promising Regions & Countries Mentioned in The Drug Abuse Testing Market Report:

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East & Africa

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Major Features of Drug Abuse Testing Market Report:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Drug Abuse Testing market
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global Drug Abuse Testing market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution.

Purchase a copy of Drug Abuse Testing Market research report @ https://www.theinsightpartners.com/buy/TIPHE100001303/?openpr-10225

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

This release was published on openPR.